Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CADLCADL
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in CANDEL THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 305,216 shares of CADL (CANDEL THERAPEUTICS INC), worth $3.1M as of 2026-Q2. The position was increased (+34.1% shares). CADL represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$3.1M

Current Shares

305,216

Total Value Change

+$2.6M

Total Shares Change

+239,980

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
305,216
+34.1%
$3.1M0.0%$10.30
34
2026-Q1
Increased
227,521
+249.6%
$1.1M0.0%$4.91
41
2025-Q4
Increased
65,085
+80.7%
$367,7310.0%$5.71
25
2025-Q3
Decreased
36,021
-54.6%
$183,7070.0%$5.40
0
2025-Q2
Increased
79,405
+45.3%
$401,7890.0%$4.90
32
2025-Q1
Decreased
54,666
-16.2%
$308,8630.0%$5.95
0
2024-Q4
New
65,236
-
$566,2490.0%$7.95
34

Other major holders of CADL: FMR LLC, RTW INVESTMENTS, LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used